نتایج جستجو برای: factor ii g20210a mutation

تعداد نتایج: 1608670  

Journal: :Clinical chemistry 2001
A Tripodi P M Mannucci

Until recently, laboratory diagnosis of thrombophilia was based on investigation of the plasmatic anticoagulant pathways to detect antithrombin, protein C, and protein S deficiencies and on the search for dysfibrinogenemia and anti-phospholipid antibodies/lupus anticoagulants. More recently, laboratory investigations have been expanded to include activated protein C (APC) resistance, attributab...

Journal: :Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 2006
F Moreira Neto D M Lourenço M A E Noguti V M Morelli I C P Gil A C S Beltrão M S Figueiredo

Sickle cell disease (SCD) is one of the most common inherited diseases in the world and the patients present notorious clinical heterogeneity. It is known that patients with SCD present activation of the blood coagulation and fibrinolytic systems, especially during vaso-occlusive crises, but also during the steady state of the disease. We determined if the presence of the factor V gene G1691A m...

امینی‌کافی‌آباد, صدیقه, سبحانی, مریم, سمیعی, شهرام, عطایی, زهرا, مقدسی, محمدحسین, کواری, مهناز,

  چکید ه   سابقه و هدف   ترومبوآمبولی وریدی یک بیماری شایع و خطرناک است. عواملی که سبب تمایل به ایجاد ترومبوز می‌شوند، ممکن است ارثی یا اکتسابی باشند. جهش پروترومبین G20210A که در منطقه ترجمه نشده ' 3 ژن فاکتور II رخ می‌دهد، همراه با افزایش ابتلا به ترومبوز در جمعیت قفقازی دیده می‌شود، البته وجود این رابطه در جمعیت‌های دیگر هنوز مورد بحث است. سطح پروترومبین در افرادی که واریانت هتروزیگوت ژن پرو...

Journal: :Pathophysiology of haemostasis and thrombosis 2002
Armando Tripodi

Until recently the laboratory diagnosis of thrombophilia consisted on investigation of the plasmatic anticoagulant pathways and the search for dysfibrinogenemia and antiphospholipid antibodies/lupus anticoagulants. More recently, the laboratory investigation has been expanded by including activated protein C (APC) resistance, due or not to the presence of the factor V Leiden mutation; hyperprot...

2017
Aydın Tunçay Elif Funda Şener Ömer Naci Emiroğulları

Objective: Major causes of mortality in patients with valvular disease are endocarditis and valve thrombosis. Oral anticoagulant drugs are used to prevent valve thrombosis. Uses of inadequate doses of medication or absence of medication use are the main reasons for the development of valve thrombosis. In addition to medical treatment or surgical treatment of patients with infective endocarditis...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید